Concepedia

Robert W. Mallett

RW

14

Publications

999

Citations

13

H-Index

1987

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Virginia Mason Medical Center

National Cancer Institute

IDEX Corporation (United States)

Robert W. Mallett is an author at Fred Hutch Cancer Center specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

1987–2019

14

Publications

14

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations · Full text

, , +17

A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts

Oliver W. Press, Melissa C. Corcoran, Krishnan Subbiah et al. · Blood · 2001 · 149 citations · Full text

A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Jody Schultz, Yukang Lin, James Sanderson et al. · PubMed · 2000 · 127 citations

, , +21

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213

Meili Zhang, Zhengsheng Yao, Kayhan Garmestani et al. · Blood · 2002 · 103 citations · Full text

Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

Krishnan Subbiah, Don K. Hamlin, John M. Pagel et al. · PubMed · 2003 · 68 citations

Rows per page

1–5 of 14